BRCA1 and neoplasm: Due to the homologous recombination repair defect (HRD) caused by the mutation of the tumor BRCA1/2 gene, the DNA cannot be repaired by the base excision repair (BER) pathway and homologous recombination repair (HRR) pathway after the use of PARPi, which eventually leads to cell death.